The following article was featured in:
Source:
National News
5/29/2026.
CVS is expanding weight-loss options in its drug plans.
The provider will begin covering Eli Lillys anti-obesity pill next month and will reinstate coverage of injectable Zepbound later this year....
Continue on to full article...
